Abstract
Statins are investigational therapies for preventing or treating Alzheimer's disease (AD) and mild cognitive impairment (MCI). Hippocampal atrophy is a characteristic feature of MCI and AD.
This study analyzed cross-sectional data from 246 nondemented elderly subjects to test the effect of lipid lowering agent (LLA) therapy on cognition and brain magnetic resonance imaging (MRI) measures of white matter lesions and hippocampal volume. The study also compared rates of hippocampal volume change over two and four years in a smaller subset.
At baseline, LLA users were younger, better educated, more likely to be male, and had higher cognitive scores. Cognitive performance also varied by age and gender, and MRI measures varied by age. After adjusting for these differences, the effect of LLA use on baseline cognition, baseline hippocampal volume, and baseline white matter lesion scores was not significant. The effect of LLA use on hippocampal volume loss at two-year and four-year follow-ups was also not significant.
This study is the first to examine statin effects on brain atrophy measured by MRI. In this cohort, statin use was not associated with rate of change of hippocampal volume. While the study was limited by a relatively small number of statin users, the findings seem consistent with three prior randomized trials that found no cognitive benefits for statins in nondemented subjects. Prospective studies in both nondemented and AD subjects may provide more conclusive answers.
Keywords: hippocampal volume, Alzheimer's disease, statin, brain atrophy, lipid lowering agent, mild cognitive impairment
Full Text
The Full Text of this article is available as a PDF (209.0 KB).
Contributor Information
P. Murali Doraiswamy, Departments of Psychiatry and Medicine (Geriatrics), Duke University Medical Center, Durham, North Carolina.
Douglas R. Mcquoid, Departments of Psychiatry, Duke University Medical Center, Durham, North Carolina..
References
- Crisby M, Carlson LA, Winblad B: Statins in the prevention and treatment of Alzheimer's disease. Alzheimer Dis Assoc Disord. 2002; 16(3): 131-136. [DOI] [PubMed] [Google Scholar]
- Doraiswamy PM: Non-cholinergic therapies for Alzheimer's disease. CNS Drugs. 2002; 16(12): 811-824. [DOI] [PubMed] [Google Scholar]
- Wagstaff LR, Mitton MW, Arvik BM, et al.: Statin-associated memory loss: Analysis of 60 case reports and review of the literature. Pharmacotherapy. 2003; 23(7):871-880. [DOI] [PubMed] [Google Scholar]
- Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet. 2002; 360(9326): 7-22. [DOI] [PubMed] [Google Scholar]
- Shepherd J, Blauw GJ, Murphy MB, et al.: Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet.2002; 360(9346): 1623-1630. [DOI] [PubMed] [Google Scholar]
- Muldoon MF, Barger SD, Ryan CM, et al.: Effects of lovastatin on cognitive function and psychological well being. Am J Med.2000; 108(7): 538-546. [DOI] [PubMed] [Google Scholar]
- Simons M, Schwärzler F, Lutjohann D, et al.: Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial. Ann Neurol.2002; 52(3): 346-350. [DOI] [PubMed] [Google Scholar]
- Park IH, Hwang EM, Hong HS, et al.: Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice. Neurobiol Aging. 2003; 24(5): 637-643. [DOI] [PubMed] [Google Scholar]
- Petrella J, Coleman E, Doraiswamy PM: Neuroimaging and the diagnosis of Alzheimer's disease: A Look to the Future. Radiology. 2003; 226(2): 315-336. [DOI] [PubMed] [Google Scholar]
- Steffens DC, Payne ME, Greenberg DL, et al.: Hippocampal volume and incident dementia in geriatric depression. Am J Ger Psychiatry.2002; 10(1): 62-71. [PubMed] [Google Scholar]
- Krishnan KR, Hays JC, Blazer DG: MRI-defined vascular depression. Am J Psychiatry.1997; 154(4): 497-501. [DOI] [PubMed] [Google Scholar]
- Sparks DL, et al. University of Arizona: press release, May 2004.